Get the Stockscreener App
241.28
0.03%
-0.07
Iqvia Holdings Inc stock is traded at $241.28, with a volume of 723.48K.
It is down -0.03% in the last 24 hours and up +7.89% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$241.35
Open:
$240.89
24h Volume:
723.48K
Relative Volume:
0.50
Market Cap:
$41.09B
Revenue:
$15.90B
Net Income/Loss:
$1.28B
P/E Ratio:
33.12
EPS:
7.2842
Net Cash Flow:
$2.21B
1W Performance:
-0.79%
1M Performance:
+7.89%
6M Performance:
+53.02%
1Y Performance:
+23.04%
1-Day Range:
$238.04
$242.44
1-Week Range:
$238.04
$247.04
52-Week Range:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
241.28 | 41.10B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
624.65 | 233.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
239.89 | 168.08B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.12 | 56.73B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
144.83 | 41.37B | 6.95B | 1.30B | 1.15B | 4.5696 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA Holdings Inc. $IQV Position Reduced by Country Trust Bank - MarketBeat
3 Medical Device Companies in Focus for Monetizing Data and Analytics - TradingView — Track All Markets
MGO One Seven LLC Acquires 8,194 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term - Yahoo Finance
PKO Investment Management Joint Stock Co Sells 4,500 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Nisa Investment Advisors LLC Raises Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Eastern Bank Buys 28,214 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Exencial Wealth Advisors LLC Acquires 19,089 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Is It Time To Reassess IQVIA (IQV) After A 22% One Year Share Price Gain - Yahoo Finance
Aug Highlights: How does IQVIA Holdings Inc compare to its peersQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of IQVIA’s Earnings Release - inkl
Nordea Investment Management AB Increases Stake in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. $IQV Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
New York State Teachers Retirement System Decreases Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
State of Alaska Department of Revenue Sells 9,112 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Treasury Yields: Is IQVIA Holdings Inc stock influenced by commodity pricesBreakout Watch & Safe Entry Zone Tips - baoquankhu1.vn
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV) - 富途牛牛
$1.55 Bn Disease Registry Software Global Markets, 2019-2024, 2024-2029F, 2034F: Shift to Value-based Care and Addressing Rare Diseases Offer Further Growth Avenues - GlobeNewswire Inc.
Understanding the Setup: (IQV) and Scalable Risk - Stock Traders Daily
Hardman Johnston Global Advisors LLC Has $22.75 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals 6.22% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
3 Reasons to Sell IQV and 1 Stock to Buy Instead - Barchart.com
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt - Yahoo Finance
Parnassus Investments LLC Has $37.90 Million Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc.'s (NYSE:IQV) P/E Still Appears To Be Reasonable - simplywall.st
Mizuho Securities Adjusts IQVIA Holdings Price Target to $266 From $250, Maintains Outperform Rating - marketscreener.com
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Moran Wealth Management LLC Takes $7.94 Million Position in IQVIA Holdings Inc. $IQV - MarketBeat
Aug Levels: Is IQVIA Holdings Inc. stock supported by strong cash flowsJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - Улправда
Will IQVIA Holdings Inc. stock gain from strong economyVolume Spike & Low Drawdown Trading Strategies - Улправда
Will IQVIA Holdings Inc. stock sustain high P E ratiosMarket Activity Summary & Short-Term High Return Ideas - ulpravda.ru
Will IQVIA Holdings Inc. (QTS) stock sustain dividend payoutsRate Cut & Verified Stock Trade Ideas - ulpravda.ru
Is IQVIA Holdings Inc. stock supported by strong cash flowsMarket Trend Review & Real-Time Volume Trigger Notifications - ulpravda.ru
Why IQVIA Holdings Inc. stock remains on watchlists2025 Biggest Moves & Community Shared Stock Ideas - Улправда
Why IQVIA Holdings Inc. stock is favored by pension fundsJuly 2025 Spike Watch & Low Volatility Stock Suggestions - ulpravda.ru
IQV: Truist Securities Maintains 'Buy' Rating, Raises Price Targ - GuruFocus
IQV: UBS Raises Price Target to $280, Maintains Buy Rating | IQV Stock News - GuruFocus
Robeco Institutional Asset Management B.V. Increases Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Why IQVIA Holdings Inc. stock is trending among retail tradersTrend Following Strategies & Outstanding Growth Portfolio - Улправда
What dividend safety score for IQVIA Holdings Inc. stockValue Traps to Avoid & Superior Capital Trading - ulpravda.ru
IQVIA HOLDINGS INC (IQV) - MSN
IQVIA Holdings, Inc. Common Stock (NY: IQV - FinancialContent
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), IQVIA Holdings (IQV) and Ascendis Pharma (ASND) - The Globe and Mail
The 24% return delivered to IQVIA Holdings' (NYSE:IQV) shareholders actually lagged YoY earnings growth - Yahoo Finance
Iqvia stock hits 52-week high at 234.33 USD By Investing.com - Investing.com Nigeria
Community Trust & Investment Co. Cuts Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA (NYSE:IQV) Hits New 12-Month HighHere's Why - MarketBeat
North Growth Management Ltd. Increases Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
62,473 Shares in IQVIA Holdings Inc. $IQV Purchased by Gateway Investment Advisers LLC - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):